This inventor holds 5 USPTO granted patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 1996-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-2005
Title: The Innovations of Sean M. Tonzi: A Trailblazer in Pharmaceutical Inventions
Introduction: Sean M. Tonzi is a prominent inventor based in Skaneateles, NY, renowned for his significant contributions to the field of pharmaceuticals. With a total of five patents to his name, Tonzi has focused his research on enzyme-related innovations that play a critical role in drug development and production.
Latest Patents: Among his notable inventions is the "Glutaryl cephalosporin amidase from Pseudomonas diminuta BS-203." This groundbreaking invention provides an enzyme that catalyzes the hydrolysis of 7-β-(4-carboxybutanamido)-cephalosporanic acid to 7-aminocephalosporanic acid and glutaric acid. Furthermore, it includes nucleic acid sequences, vectors, and host cells valuable for producing this amidase, which is instrumental in synthesizing 7-aminocephalosporanic acid. Another key patent is the "D-hydantoinase from Ochrobactrum anthropi," which outlines a novel enzyme that enantio-selectively hydrolyzes D-hydantoins to their corresponding D-N-carbamoyl-amino acids, including the encoding nucleic acids and expression vectors necessary for enzyme expression in host cells.
Career Highlights: Sean M. Tonzi has established his career at Bristol-Myers Squibb Company, a leading global biopharmaceutical firm. Here, he has been pivotal in driving innovations that support the discovery and development of new therapeutic solutions.
Collaborations: Throughout his career, Tonzi has worked alongside remarkable coworkers, including Michael Politino and William V. Burnett. Their collaborative efforts have significantly contributed to the success of their research initiatives, leading to impactful inventions in the pharmaceutical sector.
Conclusion: Sean M. Tonzi's innovative spirit and dedication have positioned him as a significant figure in the pharmaceutical industry. His patents not only advance the field of drug development but also reflect the importance of collaboration in achieving scientific breakthroughs. With ongoing contributions to the biopharmaceutical landscape, Tonzi continues to inspire future inventors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile